Expansion of cd4+cd25+foxp3+ regulatory t cells in chronic hepatitis c virus infection

Iranian Journal of Immunology

Volumn 7, Issue 3, 2010, Pages 177-185

  Hashempoor, Tayebeh ^a   Bamdad, Taravat ^a   Merat, Shahin ^b   Janzamin, Ehsan ^c   Nemati, Leila ^c   Jabbari, Hossain ^b   Sharifi, Amir Houshang ^b   Zamini, Hediyeh ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Rooyan Institute   (Iran)

Author keywords

Flowcytometry method; Hepatitis C virus; Natural regulatory T cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIGEN DETECTION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL EXPANSION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROCESS OPTIMIZATION; REGULATORY T LYMPHOCYTE; VIRUS LOAD;

ADULT; ANTIGENS, CD4; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 79952685412     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rallón NI, López M, Soriano V, García-Samaniego J, Romero M, Labarga P, et al. Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol. 2009; 155:35-43.
2. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 2003; 38:1437-1448.
3. Koup RA, Safrit JT, Cao Y, Andrews CA, Mcleod G, William B, et al. Temporal association of cellular immune responses with the initial control of viremia in primary HIV type 1 syndrome. J Virol. 1994; 68:4650-4655.
4. Godkin A, Fai W, Gallagher K, Betts G, Thomas H C, Lechler R. Expansion of hepatitis C-specific CD4+ CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage? J Allergy Clin Immunol. 2008; 121:1277-1284.
5. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 2004; 40:1062-1071.
6. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunological Rev. 2006; 212:60-73.
7. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis. 2007; 7:804-813.
8. Robertson SJ and Hasenkrug KJ. The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol. 2006; 28:51-62.
9. Alatrakchi N, Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat. 2009; 16:223-9.
10. Asseman C, Herrath MV. About CD4pos CD25pos regulatory cells. Autoimmunity Rev. 2002; 1:190-197.
11. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299:1057-1061.
12. Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, Carducci FC, et al. Increased hepatitis C virus (HCV)-specific CD4+ CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV infected patients with normal versus abnormal alanine aminotransferase levels. clin. Exp. Immunol. 2006; 144:188-196.
13. Robertson S, Hasenkrug K. The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol. 2006; 28:51-62.
14. Wang J, Ioan-Facsinay A, Van der Voort E, Huizinga TJ, Toes EM. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007; 37:129-138.
15. Barboza L, Salmen S, Goncalves L, Colmenares M, Peterson D, Montes H, et al. Antigen-induced regulatory T cells in HBV chronically infected patients. Virolgogy. 2007; 368: 41-49.
16. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology, 2007; 123:57-65.
17. Alatrakchi N, Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat. 2009; 16:223-229.
18. Boettler O, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol. 2005; 79:7860-7867.
19. Yoshizawa K, Abe H, Kubo Y, Kitahara T, Aizawa R, Matsuoka M, et al. Expansion of CD4+CD25+FoxP3+ regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol Res. 2010; 40:179-187.
20. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 2004; 40:1062-1071.
21. Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood. 2004;103:3428-3430.
22. Heeg MHJ, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach T. FOXP3 Expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology. 2009; 137:1280-1288.
23. Desmet VJ, Gerber M, Hoofnagle JH. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19:1513-1520.
24. Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol. 2007; 47:316-324.
25. Jones RC, Capen DE, Cohen KS, Munn LL, Jain RK, Duda DG. A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents. Nature protocols. 2008; 3:388-397.
26. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani GD, et al. Impairment of CD4+CD25+ regulatory Tcells in autoimmune liver disease. J Hepatol. 2004; 41:31-7.
27. Lecoeur H, Ledru E, Gougeon ML. A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes. J Immunol Methods. 1998; 217:11-26.
28. Li Sh, Jones KL, Woollard DJ, Dromey J, Paukovics G, Plebanski M, et al. Defining target antigens for CD25+FOXP3+IFN-γ- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol. 2007; 85:197-204.
29. Baecher-Allan C, Brown JA, Freeman GJ and Hafler DA. CD4+CD25high Regulatory Cells in Human Peripheral Blood. J Immunol. 2001; 167:1245-1253.
30. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J.Immun. 2006; 177:739-747.